Effect of extracorporeal shock wave therapy on different severities of carpal tunnel syndrome

Not Applicable

• Conditions: Musculoskeletal Diseases; carpal tunnel syndrome

• Registration Number: PACTR201804003293116
• Lead Sponsor: El Sahel Teaching Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-04-05
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Other
• Sex: All
• Target Recruitment: 0

Inclusion Criteria

clinically suspected to have carpal tunnel syndrome with duration of symptoms more than 3 months.
-nerve conduction studies showed evidence of median neuropathy at the wrist

Exclusion Criteria

-patients with other neuromuscular disorders, proven clinically or electrodiagnostically e.g. cervical radiculopathy, polyneuropathy. -patients with systemic diseases which may be associated with neuropathy e.g. diabetes
-Patients with carpal bone fractures and joint injuries.
-Presence of vascular disease at the wrist and/or the hand.
Patients who received any previous local intervention.(e.g. surgery)
-Patients who are receiving systemic corticosteroids

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
extracorporeal shock wave therapy may be used as a conservative treatment in patients with mild and moderate carpal tunnel syndrome

Secondary Outcome Measures

Name	Time	Method
nerve coduction studies and cross sectional area of median nerve by high resolution ultrasound may be used an objective measure to assess improvement of carpal tunnel syndrome